Abstract:The polymeric nanofiber mats were produced from polylactic acid, methylcellulose, and polyethylene glycol with 5-fluorouracil (5Fu) drug and iron oxide (Fe3O4) nanoparticles. Spectral and crystallographic studies clearly elucidated the ionic interactions, structure and nature of the mats. Fe3O4 nanoparticles <10 nm in size, along with methyl cellulose and polyethylene glycol, have significantly reduced the size of nanofiber mats. The mechanical properties for the mats was found to be challenging; however, surface wettability, swelling capacity, and drug encapsulation efficiency results were promising. A controlled drug release pattern was observed from in vitro drug release study, zero-order kinetics, and a Higuchi model. Nanofiber mats showed higher anticancer activity (78%) against MDA-MB 231 cancer cells, which reveals that a small amount of 5Fu drug (15.86%) with high levels of O2••, H2O2, and OH• radicals generated from Fe3O4 have catalyzed the Fenton's reaction to eradicate the cancer cells, in a shorter span of 24 h, itself. In addition, the apoptosis assay by dual AO/PI staining method clearly exhibited the apoptotic cancer cells by fluorescence microscopy. Incorporation of Fe3O4 nanoparticles enhanced the anticancer activity of the mats, compared to the commercially available standard 5Fu drug. Nanofiber mats significantly controlled the growth of selected pathogenic microbial strains by the action of the 5Fu drug and Fe3+ ions. The degradation of mats was investigated by an in vitro mass loss study for a period of 360 days. In a nutshell, promising nanofiber mats were produced as targeted drug delivery devices for chemotherapy.

Novel Controlled Drug Delivery System for Multiple Drugs Based on Electrospun Nanofibers Containing Nanomicelles

A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles.

Electrospun micelles/drug-loaded nanofibers for time-programmed multi-agent release.

Electrospun Micelles/Drug‐Loaded Nanofibers for Time‐Programmed Multi‐Agent Release

Controlled Dual Drug Release and in Vitro Cytotoxicity of Electrospun Poly(Lactic-Co-Glycolic Acid) Nanofibers Encapsulated with Micelles

Controlled Release of Multiple Hydrophilic and Hydrophobic Drugs and in vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid)/ZnO Nanofibers Encapsulated with Dual Drugs

Electrospun composite nanofibers containing nanoparticles for the programmable release of dual drugs

Nanofiber Prepared by Intermittent Electrospun as Controlled Drug Delivery

ueous-based dual drug loaded silk fi broin electrospun nano fi bers embedded with curcumin-loaded RSF nanospheres for drugs controlled release †

Electrospinning of Biomacromolecules for Controlled Drug Release

Preparation and Characterization of Electrospun PLGA-SF Nanofibers As a Potential Drug Delivery System

An Implantable Active-Targeting Micelle-in-nanofiber Device for Efficient and Safe Cancer Therapy.

Controlled Release and Antibacterial Activity of Antibiotic-Loaded Electrospun Halloysite/poly(lactic-Co-glycolic Acid) Composite Nanofibers.

Nanoparticles vs. nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro

Electrospun Fibre Composite for Controlled Drug Release

Size-controllable Dual Drug-Loaded Silk Fibroin Nanospheres Through a Facile Formation Process

Multiple drug-loaded electrospun PLGA/gelatin composite nanofibers encapsulated with mesoporous ZnO nanospheres for potential postsurgical cancer treatment

Controlled Release of Curcumin and Hypocrellin A from Electrospun Poly(l-Lactic Acid)/Silk Fibroin Nanofibers for Enhanced Cancer Cell Inhibition

Nanofibers Embedded with Nanoparticles as Carriers for the Controlled Release of Anticancer Drug: Promoting the Apoptosis of Breast Cancer Cell Line and Growth Inhibition of Microbial Strains

Continuous Nanostructures for the Controlled Release of Drugs

Application of Electrospun Drug-Loaded Nanofibers in Cancer Therapy